Skip to main content
. 2014 Jul 7;32(23):2463–2470. doi: 10.1200/JCO.2013.51.4109

Table 3.

Response Data

Response Treatment Strata
Platinum Sensitive (n = 80)
Platinum Refractory (n = 99)
Arm A: Ziv-Aflibercept + Topotecan (n = 41)
Arm B: Topotecan (n = 39)
Arm A: Ziv-Aflibercept + Topotecan (n = 51)
Arm B: Topotecan (n = 48)
No. % No. % No. % No. %
CR 0 0 0 0 0 0 0 0
PR* 1 2 0 0 1 2 0 0
SD 14 34 7 18 12 24 7 15
DCR 15 37 7 18 13 25 7 15
Progressive disease 18 44 29 74 29 57 33 69
Symptomatic deterioration 3 7 1 3 2 4 3 6
Early death 0 0 0 0 0 0 1 2
Assessment inadequate 5 12 2 5 7 14 4 8

Abbreviations: CR, complete response; PR, partial response; SD, stable disease; DCR, disease control rate.

*

Both partial responses were unconfirmed.

DCR = CR + PR + SD.